-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Genetic Disorders Sessions

Saturday, December 7, 2024

top

9:00 AM-7:30 PM


Poster Session I - Viewing  
Events

9:30 AM-11:00 AM


102. Iron Homeostasis and Biology: New Insights into Iron-related Proteins in Erythropoiesis and Inflammation  
Oral and Poster Abstracts


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Thrombotic Risk: The Genes We're Born with and Mutations We Acquire  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Biological Findings Associated with the Pathophysiology and Outcomes of Aplastic Anemia and PNH  
Oral and Poster Abstracts


703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Novel Cell Platforms and Delivery Strategies  
Oral and Poster Abstracts

11:15 AM-12:15 PM


Career Development Lunch
Trainee Activities and Services

12:00 PM-1:30 PM


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Know Thy(mus) Self, Know Thy Enemy: From Lymphocyte Genetic Variation to Disease  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: A Brave New World: Novel Tools, Targets and Treatments in TTP  
Oral and Poster Abstracts

2:00 PM-3:30 PM


101. Red Cells and Erythropoiesis, Excluding Iron: Effects of Inflammation on Erythropoiesis and the Niche  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Mechanisms of Hematopoietic Aging and Inflammation  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Disease Modeling and Molecular Mechanisms  
Oral and Poster Abstracts

5:30 PM-7:30 PM


Poster Session I - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster I  
Oral and Poster Abstracts


113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I  
Oral and Poster Abstracts


114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster I  
Oral and Poster Abstracts


602. Myeloid Oncogenesis: Basic: Poster I  
Oral and Poster Abstracts


617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster I  
Oral and Poster Abstracts


636. Myelodysplastic Syndromes: Basic and Translational: Poster I  
Oral and Poster Abstracts


651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster I  
Oral and Poster Abstracts


711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I  
Oral and Poster Abstracts


801. Gene Therapies: Poster I  
Oral and Poster Abstracts


803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster I  
Oral and Poster Abstracts


900. Health Services and Quality Improvement: Hemoglobinopathies: Poster I  
Oral and Poster Abstracts

Sunday, December 8, 2024

top

9:00 AM-8:00 PM


Poster Session II - Viewing  
Events

9:30 AM-11:00 AM


112. Thalassemia and Globin Gene Regulation: We're Going to Catch a Big One: Towards Targeted Therapies in Thalassemia  
Oral and Poster Abstracts


201. Granulocytes, Monocytes, and Macrophages: Uncovering Pathways Impacting Inflammation, Myeloid Proliferation and Severe Congenital Neutropenia  
Oral and Poster Abstracts


321. Coagulation and Fibrinolysis: Basic and Translational. A Coagulation Grab Bag  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Clinical and Translational Insights from Patients and Models  
Oral and Poster Abstracts


801. Gene Therapies: Gene Editing and Replacement Therapies for Hemoglobinopathies: From Bench to Bedside  
Oral and Poster Abstracts

12:00 PM-1:30 PM


323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Novel Treatments and Outcomes  
Oral and Poster Abstracts

4:30 PM-6:00 PM


113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Attenuating Sickle Cell Disease Complications – Lessons from Pre-clinical Models  
Oral and Poster Abstracts


602. Myeloid Oncogenesis: Basic: Models and Mechanisms in AML Biology  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session II - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster II  
Oral and Poster Abstracts


102. Iron Homeostasis and Biology: Poster II  
Oral and Poster Abstracts


113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II  
Oral and Poster Abstracts


114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


201. Granulocytes, Monocytes, and Macrophages: Poster II  
Oral and Poster Abstracts


321. Coagulation and Fibrinolysis: Basic and Translational: Poster II  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster II  
Oral and Poster Abstracts


501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster II  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster II  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster II  
Oral and Poster Abstracts


612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis: Poster II  
Oral and Poster Abstracts


617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster II  
Oral and Poster Abstracts


652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


653. Multiple Myeloma: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


801. Gene Therapies: Poster II  
Oral and Poster Abstracts


904. Outcomes Research: Hemoglobinopathies: Poster II  
Oral and Poster Abstracts

Monday, December 9, 2024

top

9:00 AM-8:00 PM


Poster Session III - Viewing  
Events

10:30 AM-12:00 PM


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Innovative Approaches to Improve Care for Understudied Non-Malignant Hematologic Diseases  
Oral and Poster Abstracts

4:30 PM-6:00 PM


101. Red Cells and Erythropoiesis, Excluding Iron: Erythropoiesis in Disease  
Oral and Poster Abstracts


652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Genes, Cells and Algorithms: Novel Methods of Predicting Progression in MGUS and SMM  
Oral and Poster Abstracts


801. Gene Therapies: Gene Therapies for Hemophilia, Cancer and Immunodeficiencies  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session III - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster III  
Oral and Poster Abstracts


102. Iron Homeostasis and Biology: Poster III  
Oral and Poster Abstracts


114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


201. Granulocytes, Monocytes, and Macrophages: Poster III  
Oral and Poster Abstracts


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III  
Oral and Poster Abstracts


323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster III  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III  
Oral and Poster Abstracts


603. Lymphoid Oncogenesis: Basic: Poster III  
Oral and Poster Abstracts


613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster III  
Oral and Poster Abstracts


634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


801. Gene Therapies: Poster III  
Oral and Poster Abstracts


802. Chemical Biology and Experimental Therapeutics: Poster III  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III  
Oral and Poster Abstracts